Rating Change
BTIG analysts upgraded AVITA Medical, Inc. (OTC:AVHHL) from Neutral to Buy on August 07, 2026.
BTIG analysts upgraded AVITA Medical, Inc. (OTC:AVHHL) from Neutral to Buy on August 07, 2026.

At publication ·
AVITA Medical, Inc. (OTC:AVHHL) · upgrade
At a glance
BTIG analysts upgraded AVITA Medical, Inc. (OTC:AVHHL) from Neutral to Buy on August 07, 2026.
AVITA Medical, Inc. operates in the Healthcare sector. The stock currently trades at $1.42 with a market capitalization of $97.8M.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. BTIG's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 07, 2026 | BTIG | Buy | N/A |
| May 15, 2026 | Lake Street | Buy | N/A |
| Apr 09, 2026 | D. Boral Capital | Buy | N/A |
| Apr 08, 2026 | D. Boral Capital | Buy | N/A |
| Mar 05, 2026 | Northland Capital Markets | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View AVHHL Stock Page
A rating of Buy from BTIG reflects the analyst's outlook on AVITA Medical, Inc. (OTC:AVHHL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AVHHL forecast page.
Current market data
OTC · AVHHL
$2.00
Unchanged: $0.00 · 0.00%
Live quote updated
Keep reading